Navigation Links
Shire Regenerative Medicine Initiates Phase 3 Study of ABH001 for Patients with Epidermolysis Bullosa
Date:2/8/2013

d three years and older are planned to enroll in the trial, which is targeted to be conducted in 10 to 15 sites across the US, Europe and Canada. The study will comprise ABH001 applications sufficient to cover the surface area of the wound, applied topically every 4 weeks with protocol-specified dressings until healed or for up to 24 weeks.

"We are excited that Shire Regenerative Medicine has launched this trial," said Brett Kopelan , Executive Director of the Dystrophic EB Research Association of America (DebRA ) and father to a 5-year-old girl with recessive dystrophic EB.  "While there is currently no cure for EB, I am encouraged that ABH001 is…targeting the chronic wounds that are the hallmark of this disease. I applaud Shire for pushing this forward and look forward to working closely with them as the trial progresses."  

"We are very eager to begin evaluating ABH001 as a potential wound treatment option for people with EB. We believe it has the potential to initiate and continue wound healing in this patient population," said Jeff Jonas , MD, President of Shire Regenerative Medicine. "We are committed to developing regenerative medicine solutions that enable people with life-altering conditions to lead better lives, and are encouraged by the fast track and orphan drug designations we have received to further develop this potential therapy for people, most often young children, suffering from this devastating condition."

Shire is also developing an intravenous protein replacement therapy for the treatment of dystrophic EB, which the company's Human Genetic Therapies business recently acquired from Lotus Tissue Repair, Inc. Initiation of this pivotal trial of ABH001 for patients with EB further demonstrates Shire's commitment to developing a portfolio of products targeted toward patients who suffer from this di
'/>"/>

SOURCE Shire plc
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Shire to Acquire FerroKin BioSciences, Inc., and its Phase 2 Iron Chelator Treatment
2. Heptares Grants Shire an Exclusive Worldwide Licence to Develop and Commercialise Novel Drug Candidate for CNS Disorders
3. Shire plc: First Quarter 2012 Results Date Notification - April 26, 2012
4. Shire Facebook Page Increases Awareness of Hereditary Angioedema (HAE) in Support of First HAE Awareness Day May 16th
5. Berkshire Corporation Offers Live Chat For Americas Website and Shopping Cart
6. Shire Changes its NASDAQ Ticker Symbol to SHPG
7. Dr. Jeff Jonas Appointed President of Shire Regenerative Medicine Business and Joins Shire Leadership Team
8. Shire and Boston Childrens Hospital Enter Into Broad Research Collaboration
9. Shire Reaches Agreement in Principle With U.S. Government
10. Palm Beach Residents to Learn How the Future of Regenerative Medicine Will Combat Aging
11. ODT Forum Presents Regenerative Technologies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)...  ViveBio, LLC a leading provider of products ... announced today that it has signed a distribution ... Knoxville, Tennessee to distribute ... United States . ViveST is the first ... biological specimen transport systems.  The technology enables easy, ...
(Date:8/26/2014)... (PRWEB) August 26, 2014 Genedata, ... drug discovery and life science research, today announced ... will be held in Asia, Europe, and ... global pharmaceutical companies and leading research organizations will ... best practices, case studies, and upcoming challenges in ...
(Date:8/26/2014)... N.Y. , Aug. 26, 2014 Albany ... today that William S. Marth , President and ... Morgan Stanley Global Healthcare Conference on Monday, September 8, ... live audio webcast of the presentation can be accessed ... The webcast will be archived for ...
(Date:8/26/2014)... Aug. 26, 2014 /PRNewswire-iReach/ -- The crowdfunding campaign for ... full effect on the popular crowdfunding platform Kickstarter. Backers ... for the biofeedback belt. The $75,000 funding goal for ... distribute the product. Photo - http://photos.prnewswire.com/prnh/20140825/139254 ... worn on the lower back that silently vibrates if ...
Breaking Biology Technology:ViveBio and Laboratory Procurement Services Sign Agreement for Distribution of the ViveST Line of Products 2Thought Leaders to Explore Innovations in SPR & Combination Screening at Genedata Screener User Group Meetings 2Thought Leaders to Explore Innovations in SPR & Combination Screening at Genedata Screener User Group Meetings 3PosturePulse, A Biofeedback Posture-Improving Belt, Improves Posture While Sitting or Standing 2
... steps toward putting quantum computers into real practice sending ... and transmitting the signal to a second, distant qubit ... Yale. The accomplishments are reported in sequential issues of Nature ... highlighted as the cover along with complementary work from a ...
... 3% over Fiscal 2006 to $27.5 million - ... dollars unless otherwise noted), BELLEVILLE, ON, Sept. 26 ... technology-driven Canadian,biopharmaceutical company, today announced financial results for its ... announcements of the first shipment and commercial usage of,our ...
... Sept. 26 Nastech,Pharmaceutical Company Inc. (Nasdaq: NSTK ... in New York City on Thursday, October 4, 2007,from ... Westin New York at Times,Square, on 270 West 43rd ... C. Quay, M.D., Ph.D., Chairman, President and,Chief Executive Officer ...
Cached Biology Technology:Yale scientists make 2 giant steps in advancement of quantum computing 2Yale scientists make 2 giant steps in advancement of quantum computing 3Bioniche Reports Fiscal 2007 Year-End Results 2Bioniche Reports Fiscal 2007 Year-End Results 3Bioniche Reports Fiscal 2007 Year-End Results 4Bioniche Reports Fiscal 2007 Year-End Results 5Bioniche Reports Fiscal 2007 Year-End Results 6Bioniche Reports Fiscal 2007 Year-End Results 7Bioniche Reports Fiscal 2007 Year-End Results 8Bioniche Reports Fiscal 2007 Year-End Results 9Bioniche Reports Fiscal 2007 Year-End Results 10Nastech to Host 2007 Analyst and Institutional Investor Day 2Nastech to Host 2007 Analyst and Institutional Investor Day 3
(Date:8/25/2014)... Mo. Boron deficiency is one of the most ... eastern half of the United States are plagued by ... are required to supplement their soil with boron; however, ... plants utilize the essential nutrient. Now, researchers at the ... integral role in development and reproduction in corn plants. ...
(Date:8/25/2014)... certain type of biomolecule built like a nano-Christmas tree. ... sugary ornaments. , It,s those ornaments that get all ... glycoconjugate,s lowly "tree" basically holds the sugars in place ... other molecules. , Now a chemist at Michigan Technological ... a good deal more than a simple prop. , ...
(Date:8/25/2014)... Services of Western Australia, a bushfire ADVICE remains for people ... Broome, and Cape Leveque Road approximately 40 kilometres north of ... threat to lives or homes but there is a lot ... of fires burning in the area on both sides of ... are also burning on the eastern side of Cape Leveque ...
Breaking Biology News(10 mins):Researchers find boron facilitates stem cell growth and development in corn 2
... (Oct. 19, 2008) Researchers have discovered a mechanism for ... childhood tumor. The tumors, which are made ... of children of European descent, with girls more frequently afflicted ... often as a single, blood-red lump on the head or ...
... The first reports of the successful reprogramming of adult ... which by all appearances looked and acted liked embryonic stem ... inefficient: Only one out of 10,000 cells could be persuaded ... researchers led by Juan Carlos Izpisa Belmonte at the Salk ...
... helps celebrate the season. While overindulging leads to calorie ... chocolate can actually make one feel and even look ... of CHOCOLATEA HEALTHY PASSION (Prometheus Books, $19.98), can explain ... its history, culture, sensory pleasures and more. , Science ...
Cached Biology News:Researchers identify Achilles heel of common childhood tumor 2Salk researchers successfully reprogram keratinocytes attached to a single hair 2Salk researchers successfully reprogram keratinocytes attached to a single hair 3Lower your blood pressure, hydrate your skin and reduce dental plaque -- with chocolate? 2Lower your blood pressure, hydrate your skin and reduce dental plaque -- with chocolate? 3
Troponin I Immunogen: Full length native protein (purified) (Human). Storage: -20 C, Avoid Freeze/Thaw Cycles...
...
Troponin I (22B11)...
... freezers , Ultima II Series ... storage, Ultima II represents the finest, most ... purpose and blood bank configurations, each Ultima ... control system with built-in voltage boost and ...
Biology Products: